氢化可的松-17-戊酸酯结构式
|
常用名 | 氢化可的松-17-戊酸酯 | 英文名 | Hydrocortisone Valerate |
|---|---|---|---|---|
| CAS号 | 57524-89-7 | 分子量 | 446.57600 | |
| 密度 | 1.21g/cm3 | 沸点 | 595.1ºC at 760mmHg | |
| 分子式 | C26H38O6 | 熔点 | 217-220 °C | |
| MSDS | 中文版 美版 | 闪点 | 195ºC | |
| 符号 |
GHS08 |
信号词 | Warning |
氢化可的松-17-戊酸酯用途Hydrocortisone 17-valerate (Cortisol 17-valerate) 是噻唑烷类化合物。 |
| 中文名 | 氢化可的松 17-戊酸酯 |
|---|---|
| 英文名 | cortisol 17-valerate |
| 中文别名 | 氢化可的松戊酸酯 |
| 英文别名 | 更多 |
| 密度 | 1.21g/cm3 |
|---|---|
| 沸点 | 595.1ºC at 760mmHg |
| 熔点 | 217-220 °C |
| 分子式 | C26H38O6 |
| 分子量 | 446.57600 |
| 闪点 | 195ºC |
| 精确质量 | 446.26700 |
| PSA | 100.90000 |
| LogP | 3.52270 |
| InChIKey | FZCHYNWYXKICIO-FZNHGJLXSA-N |
| SMILES | CCCCC(=O)OC1(C(=O)CO)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C |
| 外观性状 | 固体 |
| 折射率 | 1.56 |
| 储存条件 | -20°C, 惰性气体 |
| 符号 |
GHS08 |
|---|---|
| 信号词 | Warning |
| 危害声明 | H351 |
| 警示性声明 | P281 |
| 个人防护装备 | Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| 危害码 (欧洲) | Xn |
| 风险声明 (欧洲) | 40 |
| 安全声明 (欧洲) | 22-36 |
| 危险品运输编码 | NONH for all modes of transport |
| WGK德国 | 3 |
| 氢化可的松-17-戊酸酯上游产品 0 | |
|---|---|
| 氢化可的松-17-戊酸酯下游产品 1 | |
|
Topical corticosteroid compounding: effects on physicochemical stability and skin penetration rate.
J. Am. Acad. Dermatol. 21(5 Pt 1) , 979-84, (1989) Compounding compatibility studies of four corticosteroid cream products and four commonly added chemicals are presented. Physical alteration, chemical stability, micropreservative challenge status, an... |
|
|
Addition of a topically applied corticosteroid to a modified Goeckerman regimen for treatment of psoriasis: effect on duration of remission.
J. Am. Acad. Dermatol. 13(5 Pt 1) , 784-91, (1985) A double-blind parallel group study was undertaken to assess the effect of adding a topically applied corticosteroid cream to a modified Goeckerman regimen to treat patients with psoriasis. Nineteen p... |
|
|
Temporal infiltration of leukocyte subsets into mouse skin inflamed with phorbol ester.
Agents Actions 37(3-4) , 260-7, (1992) We have previously shown that multiple topical applications, over 11 days, of the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) induces a persistent inflammatory reaction characterized by e... |
|
实验名称:Primary qHTS assay for inhibitors of alpha-synuclein gene (SNCA) expression
来源:NCGC
External Id:SNCA-p-activity-luciferase
|
|
实验名称:Fluorescence-based cell-based primary high throughput screening assay to identify ago...
来源:The Scripps Research Institute Molecular Screening Center
靶标:muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id:CHRM1_AG_FLUO8_1536_1X%ACT PRUN
|
|
实验名称:Cytochrome P450 Family 1 Subfamily A Member 2 (CYP1A2) small molecule antagonists: lu...
来源:824
External Id:CYP273
|
|
实验名称:Fluorescence-based cell-based primary high throughput screening assay to identify pos...
来源:The Scripps Research Institute Molecular Screening Center
靶标:muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id:CHRM1_PAM_FLUO8_1536_1X%ACT PRUN
|
|
实验名称:qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity
来源:NCGC
External Id:HERG01
|
|
实验名称:uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay
来源:Burnham Center for Chemical Genomics
靶标:cystic fibrosis transmembrane conductance regulator [Homo sapiens]
External Id:SBCCG-A764-CF-PAF-Primary-Assay
|
|
实验名称:Fluorescence-based cell-based primary high throughput screening assay to identify ant...
来源:The Scripps Research Institute Molecular Screening Center
靶标:muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id:CHRM1_ANT_FLUO8_1536_1X%INH PRUN
|
|
实验名称:Primary qHTS for inhibitors of NSP2Pro chikungunya virus (CHIKV)
来源:NCGC
External Id:APP-Toga-CHIKV-nsp2-p
|
| CORTISOL 17-VALERATE |
| Flexicort |
| Westcort |
| HYDROCORTISONEVALERATE,USP |
| Hydrocortisone Valerate (200 mg) |
| cortisol valerate |
| hydrocortisone valerat |
| hydrocortisone-17-valerate |
| HYDROCORTISONE VALERATE |